Tags : Reimbursement

Novartis Reports the Reimbursement of Kisqali as 1L Treatment for

Shots: The reimbursement of Kisqali is a testament to the ongoing need for public access to the treatment. The Canadian Province, Quebec will reimburse Kisqali + Letrozole under the public drug program as 1L treatment for HR+, HER2-negative advanced or metastatic breast cancer in post-menopausal women Novartis will collaborate with remaining province and territories in […]Read More

Medtronic’s MiniMed 670G Insulin Pump System Receives Reimbursement for Patients

Shots: Medtronic reports that it has secured for its reimbursement for the MiniMed 670G insulin pump system with the German Federal Association of the Statutory Health Insurances (GKV-SV). The reimbursement agreement will be effective from Aug 29, 2019 The granted reimbursement will increase the accessibility of Medtronic’s MiniMed 670G Insulin pump system to more patients […]Read More